Prevalence of Obesity and Its Influence on Achievement of Cardiometabolic Therapeutic Goals in Chinese Type 2 Diabetes Patients: An Analysis of the Nationwide, Cross-Sectional 3B Study
Open accessThe DOI matches its Crossref record; 35 of the 35 references it cites were found in a registry or an index.
Abstract
BACKGROUND: There are few data on the prevalence of obesity and its influence on achieving blood glucose, blood pressure, and blood lipid (3B) goals in Chinese type 2 diabetes outpatients. METHODS: Patient demographic data, anthropometric measurements, medications, and blood glucose and lipid profiles of 24,512 type 2 diabetes patients from a large, geographically diverse study (CCMR-3B) were analyzed. Using cut-points for body mass index (BMI) and waist circumference (WC) recommended by the Working Group on Obesity in China, overweight and obesity were defined as BMIs of 24-27.9 kg/m2 and ≥28.0 kg/m2. Central obesity was defined as a waist circumference ≥80 cm in women and ≥85 cm in men. The 3B therapeutic goals were HbA1c<7.0%, BP<140/90 mmHg and LDL-C<2.6 mmol/L. RESULTS: Overall, 43.0% of type 2 diabetes patients were overweight and 16.7% were obese; 13.3% of overweight and and 10.1% of obese patients achieved all the 3B target goals. Overweight or obese patients were less likely to achieve 3B goals than those with normal BMIs. More than a half the overweight or obese patients (69.6%) were centrally obese. Patients with abdominal obesity were less likely to achieve cardiometabolic targets than those without abdominal obesity. In multivariate logistic regression analysis, female, higher BMI and waist circumference, smoking, drinking, sedentary lifestyle, and longer diabetes duration were significantly correlated with failure to achieve 3B control goals. CONCLUSIONS: Obesity is highly prevalent and associated with poor 3B control in Chinese type 2 diabetes patients. In clinical practice, more attention and resources should focus on weight loss for such patients.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“In contrast to that observed in western countries, a study in China found that 50.3% of T2D patients were not overweight,34”
From A review of current trends with type 2 diabetes epidemiology, aetiology, pathogenesis, treatments and future perspectives (2021) · cites this paper as [34]
Experimental — accuracy not yet measuredIn the citing paper
“However, in some Asian countries, ~50% of patients are not overweight.34,35”
From A review of current trends with type 2 diabetes epidemiology, aetiology, pathogenesis, treatments and future perspectives (2021) · cites this paper as [34]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Standards of Medical Care in Diabetes
Power, D. (2006) · Diabetes Care · doi:10.2337/diacare.29.02.06.dc05-1593 · Cited by 8,673
Prevalence of obesity, diabetes, and obesity-related health risk factors, 2001
Mokdad, A. H., Ford, E. S., Bowman, B. A., Dietz, W. H., Vinicor, F., Bales, V. S., & Marks, J. S. (2003) · JAMA · doi:10.1001/jama.289.1.76 · Cited by 5,866
Standards of medical care in diabetes—2014
American Diabetes Association (2014) · Diabetes Care · doi:10.2337/dc14-s014 · Cited by 4,572
Prevalence of Diabetes among Men and Women in China
Yang, W., Lu, J., Weng, J., Jia, W., Ji, L., Xiao, J., Shan, Z., Liu, J., Tian, H., Ji, Q., et al. (2010) · New England Journal of Medicine · doi:10.1056/nejmoa0908292 · Cited by 3,031
Self-citationCardiovascular effects of intensive lifestyle intervention in type 2 diabetes
The Look AHEAD Research Group (2013) · New England Journal of Medicine · doi:10.1056/nejmoa1212914 · Cited by 2,908
(2013) · European Heart Journal · doi:10.1093/eurheartj/eht108 · Cited by 1,955
(2002) · PubMed · Cited by 1,755
Bei‐Fan, Z., & the Cooperative Meta‐analysis Group of Working Group on Obesity in China (2002) · Asia Pacific Journal of Clinical Nutrition · doi:10.1046/j.1440-6047.11.s8.9.x · Cited by 1,270
Zhou, Cooperative, B.-F., & on (2002) · 生物医学与环境科学:英文版 · Cited by 992
Research works printed but not linked: 1
- Chinese Diabetes Society. China Guideline for Type 2 Diabetes. Chin J Diabetes Mellitus. 2014; 6: 447– 498
Cited by
Reed, J., Bain, S., & Kanamarlapudi, V. (2021) · Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy · doi:10.2147/dmso.s319895 · Cited by 441
on behalf of CCMR-3B STUDY Investigators, Tao, X., Li, J., Zhu, X., Zhao, B., Sun, J., Ji, L., Hu, D., Pan, C., Huang, Y., et al. (2016) · Cardiovascular Diabetology · doi:10.1186/s12933-016-0376-7 · Cited by 80
“The study design and population have been previously described [15, 16].”
MethodSelf-citationKenawy, E., Seggiani, M., Cinelli, P., Elnaby, H. M. H., & Azaam, M. M. (2020) · European Polymer Journal · doi:10.1016/j.eurpolymj.2020.109769 · Cited by 71
Zhang, P., Wang, R., Gao, C., Jiang, L., Lv, X., Song, Y., & Li, B. (2016) · PLOS ONE · doi:10.1371/journal.pone.0160402 · Cited by 64
“Both of them indicated that hypertension, diabetes and hyperlipidemia had a positive association with central obesity, which is consistent with previous studies [27, 28].”
ResultAssociation of obesity with hypertension and dyslipidemia in type 2 diabetes mellitus subjects
Anari, R., Amani, R., Latifi, S. M., Veissi, M., & Shahbazian, H. B. (2016) · Diabetes & Metabolic Syndrome Clinical Research & Reviews · doi:10.1016/j.dsx.2016.07.004 · Cited by 71
Sudheer, S. M., Gangwar, P., Usmani, Z., Sharma, M., Sharma, V. K., Sana, S. S., Almeida, F. B. D. R., Dubey, N. K., Singh, D. P., Dilbaghi, N., et al. (2021) · Biochimie · doi:10.1016/j.biochi.2021.10.010 · Cited by 53
Vugic, L., Colson, N., Nikbakht, E., Gaiz, A. A., Holland, O. J., Kundur, A., & Singh, I. (2019) · Journal of Functional Foods · doi:10.1016/j.jff.2019.103596 · Cited by 49
“CCL2 can also induce increased plasma amylin, which is associated with the maintenance of blood glucose levels (Zhou et al., 2016).”
BackgroundMiyazawa, I., Kadota, A., Miura, K., Okamoto, M., Nakamura, T., Ikai, T., Maegawa, H., & Ohnishi, A. (2018) · Endocrine Journal · doi:10.1507/endocrj.ej17-0415 · Cited by 38
“Other studies have reported that diabetic patients with obesity had poor control of blood glucose, blood pressure and serum lipids, although they were more likely to be receiving antihypertensive drugs and lipidlowering drugs compared with non-obese patients [4, 5].”
ResultZhou, R., Li, F., Chen, G., Fu, Q. J., Gu, S., & Wu, X. (2020) · Journal of Diabetes · doi:10.1111/1753-0407.13075 · Cited by 34
Seng, J. J. B., Monteiro, A. Y., Kwan, Y. H., Zainudin, S. B., Tan, C. S., Thumboo, J., & Low, L. L. (2021) · BMC Medical Research Methodology · doi:10.1186/s12874-021-01209-w · Cited by 34
Janković, N., Ristovski, J. T., Vraneš, M., Tot, A. S., Petronijević, J., Joksimović, N., Stanojković, T., Crnogorac, M. Đ., Petrović, N., Boljević, I., et al. (2019) · Bioorganic Chemistry · doi:10.1016/j.bioorg.2019.02.026 · Cited by 29
Huang, L., Zhang, Y., Wang, Y., Shen, X., & Yan, S. (2019) · Canadian Journal of Diabetes · doi:10.1016/j.jcjd.2019.11.005 · Cited by 28
Zhang, Y., Li, Y., Dong, Y., Wu, Y., Bian, R., Ji-hu, L., & Ji, L. (2019) · Journal of Clinical Hypertension · doi:10.1111/jch.13675 · Cited by 27
Self-citationJi, Q., Chai, S., Zhang, R., Li, J., Zheng, Y., & Rajpathak, S. N. (2024) · Frontiers in Endocrinology · doi:10.3389/fendo.2024.1362433 · Cited by 25
Self-citationJiang, X., Jiang, H., Chen, Y., Wu, X.-A., Yu, X.-L., Liu, L., & Li, M. (2021) · Diabetes Metabolic Syndrome and Obesity · doi:10.2147/dmso.s290029 · Cited by 30
“It was reported that compared with the T2DM patients without central obesity (< 80 cm in female and < 85 cm in the male), the insulin resistance of T2DM patients with central obesity (≥80 cm in female and ≥85 cm in the male) was more inadequate, thereby leading to high glycemic control.(31) In addition, a study found…”
ResultHan, Y., Cheng, B., Guo, Y., Wang, Q., Yang, N., & Lin, P. (2021) · Frontiers in Endocrinology · doi:10.3389/fendo.2021.779636 · Cited by 24
“0 mg/dl and/or with microalbuminuria); (2) serious liver disease excluding fatty liver (aspartate aminotransferase and/or alanine aminotransferase levels >100 IU/L) and pancreatic disease; (3) acute heart failure within 3 months or apparent chronic heart failure; (4) active malignancy; (5) pregnancy; (6) serious infec…”
Backgroundon behalf of CCMR-3B STUDY Investigators, Huang, Y., Li, J., Zhu, X., Sun, J., Ji, L., Hu, D., Pan, C., Tan, W., Jiang, S., et al. (2017) · Acta Diabetologica · doi:10.1007/s00592-017-0981-2 · Cited by 21
“Subsequent analysis revealed that poorer metabolic control was associated with low socioeconomic status [8] and obesity [9], as well as the underuse of the ACEI/ARB in those with hypertension in albuminuria [10].”
BackgroundSelf-citationFeng, W.-Y., Li, X.-D., Li, J., Shen, Y. L., & Li, Q. (2021) · International Journal of Environmental Research and Public Health · doi:10.3390/ijerph182111439 · Cited by 26
“Hypertension and hyperlipidemia had a positive association with central obesity, which is consistent with previous studies [32].”
ResultJing, Y., Hong, T., Bi, Y., Hu, D., Chen, G., Li, J., Zhang, Y., Zhang, R., Ji, L., & Zhu, D. (2018) · Journal of Diabetes Investigation · doi:10.1111/jdi.12785 · Cited by 22
Self-citationSugary beverages are associated with cardiovascular risk factors in diabetic patients
Anari, R., Amani, R., & Veissi, M. (2019) · Journal of Diabetes & Metabolic Disorders · doi:10.1007/s40200-019-00383-5 · Cited by 19
Serum fetuin-A levels in obese and non-obese subjects with and without type 2 diabetes mellitus
Zhou, Z., Ju, H., Sun, M., Chen, H., Fu, Q.-P., & Jiang, D. (2017) · Clinica Chimica Acta · doi:10.1016/j.cca.2017.11.023 · Cited by 21
A culturally sensitive nurse‐led structured education programme in patients with type 2 diabetes
Liu, Y., Jiang, X., Jiang, H., Lin, K., Li, M., & Ji, L. (2019) · International Journal of Nursing Practice · doi:10.1111/ijn.12757 · Cited by 25
Self-citationDeng, H., Lin, S., Yang, X., Lv, J., Luo, S., Zeng, L., Weng, J., Xu, W., & On Behalf of the CONFIDENCE Group (2019) · Journal of Diabetes · doi:10.1111/1753-0407.12883 · Cited by 20
“7% are obese.(2) Conversely, modest sustained weight loss of more than 5% in T2D patients can lead to clinically meaningful metabolic benefits.”
BackgroundSelf-citationObesity among type 2 diabetes mellitus at Sidama Region, Southern Ethiopia
Wube, T. B., Menjetta, T., & Nuru, M. M. (2022) · PLoS ONE · doi:10.1371/journal.pone.0266716 · Cited by 13
“14%) [18] and lower than the study done in Northern Ethiopia, Tigray region (53.”
BackgroundResultInfluentialObstructive Sleep Apnea and Diabetic Nephropathy
Misra, A., & Shrivastava, U. (2016) · Diabetes Technology & Therapeutics · doi:10.1089/dia.2016.0147 · Cited by 12
Sun, P., & Lian, J. (2016) · Postgraduate Medicine · doi:10.1080/00325481.2016.1151326 · Cited by 13
“[32,33] Our study methodology included a variety of features which have not yet been incorporated within one single study of this type: adjustment for various patient demographic and clinical characteristics, inclusion of patients with both private and public insurance, nationwide US database, longitudinal design fact…”
MethodFood obesogens as emerging metabolic disruptors; A toxicological insight
Ravichandran, G., Kumar, D., Arunachalam, A., & Thilagar, S. (2021) · The Journal of Steroid Biochemistry and Molecular Biology · doi:10.1016/j.jsbmb.2021.106042 · Cited by 13
Ren, Q., Ji, L., Lu, J., Li, Y., Li, Q., Lin, S., Lv, X., Wang, L., Xu, Y., Guo, X., et al. (2019) · Journal of Diabetes and its Complications · doi:10.1016/j.jdiacomp.2019.107464 · Cited by 9
Self-citationHaymana, C., Sönmez, A., Demirci, İ., Yaylalı, G. F., Nuhoğlu, İ., Sancak, S., Yılmaz, M., Altuntaş, Y., Dınççağ, N., Sabuncu, T., et al. (2020) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2020.108556 · Cited by 9
Kaku, K., Yamamoto, K., Fukushima, Y., Mizuno, S., & Nitta, D. (2022) · Expert Opinion on Drug Safety · doi:10.1080/14740338.2022.2062322 · Cited by 9
Motadi, S. A., Veldsman, T., Mohlala, M., & Mabapa, N. S. (2018) · Journal of Nutrition and Health Sciences · doi:10.15744/2393-9060.5.102 · Cited by 7
Lu, L., Liu, B., & Ma, Y. (2023) · Diabetes Metabolic Syndrome and Obesity · doi:10.2147/dmso.s398475 · Cited by 7
Cai, X., & Ji, L. (2021) · Diabetes Therapy · doi:10.1007/s13300-021-01079-x · Cited by 6
Self-citationOkatan, E. N., & Turan, B. (2019) · Canadian Journal of Physiology and Pharmacology · doi:10.1139/cjpp-2019-0006 · Cited by 4
Hejjaji, V., Martínez, J. J. G., Tang, F., Garnelo, J. B., Cooper, A., Medina, J., Mutiozabal, M. S., Khunti, K., Nicolucci, A., Shestakova, M. V., et al. (2022) · Diabetes Obesity and Metabolism · doi:10.1111/dom.14745 · Cited by 4
Self-citationSeuring, T., Serneels, P. M., Suhrcke, M., & Bachmann, M. O. (2020) · Economics & Human Biology · doi:10.1016/j.ehb.2020.100925 · Cited by 5
“Research shows that behaviour changes after a diabetes diagnosis can positively affect health and the risk of subsequent cardiovascular events (Long, Cooper, Wareham, Griffin, & Simmons, 2014; Zhou et al., 2016).”
BackgroundRelationships between Body Weight Perception and Weight Management: Practices among Adolescents
Dhungel, K. U., & Bhattarai, B. (2020) · Janaki Medical College Journal of Medical Science · doi:10.3126/jmcjms.v8i1.31555 · Cited by 3
“of one’s weight as “underweight” or “normal weight” or “overweight” irrespective of actual body mass index [3, 12].”
Zhang, J., Xian, T.-Z., Teng, Y., Wang, X., Wu, M.-X., Li, C., Wang, W., Man, F., Zhang, X., Wang, X., et al. (2022) · International Journal of Clinical Practice · doi:10.1155/2022/7128859 · Cited by 2
“Approximately 60% of T2DM patients in China are overweight and obese [2].”
Lu, D., Jiang, W., Ai, D., Cen, C., Ou, Q., Chen, K., & Zhang, J. (2025) · Journal of Diabetes Investigation · doi:10.1111/jdi.14376 · Cited by 2
“Despite multiple oral hypoglycemic medications and insulin intervention, the control rate of glycosylated hemoglobin (HbA 1c ) in patients with diabetes in China is still 50% 2 .”
Epidemiology, Control, and Cardiovascular Outcomes of Dyslipidemia in Diabetes
Fan, W., & Wong, N. D. (2023) · Contemporary diabetes · doi:10.1007/978-3-031-26681-2_32 · Cited by 2
Serum fetuin-A in diabetic and nondiabetic hemodialysis patients
Akad, A. A., Tawfeik, H., Kamel, H., & Mahmoud, E. (2023) · Minia Journal of Medical Research · doi:10.21608/mjmr.2023.187092.1300 · Cited by 3
Prevalence of Adult Obesity in the Guadeloupean Diabetic Population
Pierre, K. D. (2017) · European Journal of Preventive Medicine · doi:10.11648/j.ejpm.20170506.12
“And, in a cohort of 4098 diabetic patients between 45-54 years, 55- 64 years then 65 years and more there are respectively 20,1%, 29,4% and 40,6% of obese [28].”
BackgroundBenzodiazepines: pharmacokinetic profile and clinical implications.
Gwee, M. C. E. (1985) · PubMed
Muratova, O. V. (2020) · Bulletin of Problems Biology and Medicine · doi:10.29254/2077-4214-2020-3-157-283-287
Mohammadi, M. M., Rajabnia, M., Forghani, M. S., Rahmani, K., & Bahadoram, M. (2020) · Journal of Renal Injury Prevention · doi:10.34172/jrip.2021.34
“indicates overweight, which was consistent with the studied by Wei et al (18), Zhou et al (19) and Saleem et al (20).”
ResultInfluentialKaraaslan, H., Göçer, E. G., & Doğan, F. (2025) · Journal of Diabetes & Metabolic Disorders · doi:10.1007/s40200-025-01757-8 · Cited by 1
Seng, J. J. B., Monteiro, A. Y., Kwan, Y. H., Zainudin, S. B., Tan, C. S., Thumboo, J., & Low, L. L. (2021) · Figshare · doi:10.6084/m9.figshare.14205179
Seng, J. J. B., Monteiro, A. Y., Kwan, Y. H., Zainudin, S. B., Tan, C. S., Thumboo, J., & Low, L. L. (2021) · Figshare · doi:10.6084/m9.figshare.14205170
Seng, J. J. B., Monteiro, A. Y., Kwan, Y. H., Zainudin, S. B., Tan, C. S., Thumboo, J., & Low, L. L. (2021) · Figshare · doi:10.6084/m9.figshare.14205173
Seng, J. J. B., Monteiro, A. Y., Kwan, Y. H., Zainudin, S. B., Tan, C. S., Thumboo, J., & Low, L. L. (2021) · Figshare · doi:10.6084/m9.figshare.14205167
Seng, J. J. B., Monteiro, A. Y., Kwan, Y. H., Zainudin, S. B., Tan, C. S., Thumboo, J., & Low, L. L. (2021) · Figshare · doi:10.6084/m9.figshare.14205176
Emerging therapeutic approaches in neurobiology of type 2 diabetes
Kumar, U., Garg, S., Shrivastav, A., Sharma, B., Arora, B., Sahu, B., & Gupta, M. (2026) · Elsevier eBooks · doi:10.1016/b978-0-443-32848-0.00023-6
Pîrșcoveanu, D. F. V., Pluta, I. D., Dîrnu, R., Vlădulescu, C., Trașcă, D.-M., Văruț, R. M., Kamal, A. M., Stoica, M., Pura, G., Popa, R., et al. (2026) · Molecules · doi:10.3390/molecules31142415
Consumo de alcohol y control glucémico en adultos con diabetes mellitus tipo 2: revisión sistemática
González, K. K. E., Castillo, M. M. A., Galera, S. A. F., Cisneros, M. A. L., & Chávez, J. J. C. (2026) · Horizon Interdisciplinary Journal · doi:10.56935/hij.v4i3.74
Deng, L., Jiang, X., Li, R., Zhao, H., Yuan, M., Wang, C., Zhao, R., Hu, Y., & Fan, G. (2026) · Research Square · doi:10.21203/rs.3.rs-11049427/v1
Metadata
- Authors
- Zhou, X., Ji, L., Ran, X., Su, B., Ji, Q., Pan, C., Weng, J., Ma, C., Hao, C., Zhang, D., Hu, D., & CCMR Advisory Board and CCMR-3B Study Investigators
- Affiliations
- Peking University (CN)
- Sichuan University (CN)
- Dalian Medical University (CN)
- Xijing Hospital (CN)
- Chinese PLA General Hospital (CN)
- Sun Yat-sen University (CN)
- Capital Medical University (CN)
- VitalStrategic Research Institute (US)
- Peking University People's Hospital (CN)
- Corresponding author
- Ji, Linong
- ORCID
- Venue
- PLOS ONE
- Publisher
- Public Library of Science (PLoS)
- Published
- 2016-01-04
- Volume
- 11
- Issue
- 1
- Pages
- e0144179
- ISSN
- 1932-6203 (ISSN-L)
- PMC
- PMC4699817
- OpenAlex
- W2225024458
- Cited by
- 56
- References
- 34
- Citations by year
- 2026: 4 · 2025: 2 · 2024: 1 · 2023: 3 · 2022: 4 · 2021: 13 · 2020: 7 · 2019: 8 · 2018: 3 · 2017: 5 · 2016: 5
- FWCI
- 7.04
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- Locations
- PLoS ONE (publishedVersion, cc-by)
- Europe PMC (PubMed Central) (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion)
- Radboud Repository (Radboud University) (submittedVersion)
- Radboud Repository (Radboud University) (submittedVersion, other-oa)
- Topics
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes, Cardiovascular Risks, and Lipoproteins
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Treatment and Management
- Health Sciences › Medicine › Public Health, Environmental and Occupational Health › Obesity, Physical Activity, Diet
- Keywords
- obesity, type 2 diabetes, glycemic control, blood pressure control, lipid control, overweight, abdominal obesity, waist circumference, body mass index, Chinese patients, weight loss
- MeSH terms
- Adult, Aged, Alcohol Drinking, Blood Glucose, China, Cross-Sectional Studies, Diabetes Mellitus, Type 2, Female, Glycated Hemoglobin, Humans, Hypoglycemic Agents, Lipids, Male, Middle Aged, Obesity, Outpatients, Risk Factors, Smoking, Time Factors, Comorbidity, Body Mass Index, Asian People, Dyslipidemias, Overweight, Waist Circumference, Obesity, Abdominal, Sedentary Behavior
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.